Abstract:Primary aldosteronism (PA) is a common cause of secondary hypertension with a prevalence rate of approximately 5% to 10%. The characteristics of PA include excessive aldosterone secretion and inhibition of the renin-angiotensin system. Aldosterone-producing adenoma (APA) is a common subtype of PA, accounting for about 40% to 50% of PA cases. [ 1 ] Compared with essential hypertension, the incidence of stroke and myocardial infarction in PA patients is significantly higher, so early diagnosis and active treatment are crucial. [ 2 ] Obstructive sleep apnea (OSA) is a common sleep-related disorder. In recent years, with the rise in overweight and obese individuals, along with population aging, the occurrence of OSA has been escalating, becoming a pressing public health concern. [ 3 ] OSA poses a significant threat to life safety and may result in accidental deaths and sudden fatalities during sleep. [ 4 ] Furthermore, it exhibits a strong correlation with metabolic dysregulation, cardiovascular and nervous system impairments, as well as memory decline and cancer development. [ 5 ] Multiple studies reveal a close link between OSA and PA. A cross-center, multi-ethnic study found that 67.6% of PA patients had OSA, with a significant correlation between plasma aldosterone and OSA severity. [ 6 ] Nakamura et al discovered that 55% (39 of 71) of Japanese PA patients had OSA. [ 7 ] Therefore, conducting OSA examinations and implementing management strategies for PA patients is imperative. A meta-analysis revealed that OSA affects nearly 46% of 2335 PA patients (95% CI = 39–54%). Notably, hypertensive patients with PA have a significantly higher OSA prevalence compared to those without PA (OR = 2.01, 95% CI = 1.37–2.95, P < .001). In addition, the study demonstrated that approximately 27% of 3498 OSA patients also had PA (95% CI = 24–29%). Notably, the prevalence of PA was significantly higher in OSA patients compared to non-OSA patients (OR = 2.03, 95% CI = 1.30–3.16, P = .002). [ 8 ] Di Murro et al reported that approximately 34% of hypertensive patients with OSA also have PA. [ 9 ] Increasing research indicates that there is a complex interaction between OSA and PA, and they are likely to share some pathological mechanisms. [ 10 , 11 ] Despite numerous studies exploring the pathophysiological links between PA and OSA, the search for common genetic factors remains inadequate.

Elevated renin activity and change in sleep apnea with primary aldosteronism

The Prevalence of Obstructive Sleep Apnea in Patients With Primary Aldosteronism

Primary Aldosteronism and Sleep Apnea Syndrome

Stroke Risks in Primary Aldosteronism with Different Treatments: A Systematic Review and Meta-Analysis

Exploring the pathogenesis linking primary aldosteronism and obstructive sleep apnea via bioinformatic analysis

Primary Aldosteronism and Obstructive Sleep Apnea: A Meta-Analysis of Prevalence and Metabolic Characteristics

Changes of Aldosterone Levels in Patients with Type 2 Diabetes Complicated by Moderate to Severe Obstructive Sleep Apnea–hypopnea Syndrome Before and after Treatment with Continuous Positive Airway Pressure

Sleep disturbances in primary aldosteronism are associated to depressive symptoms - Could specific mineralocorticoidreceptors be a common pathway?

The Study of Screening Rates of Primary Aldosteronism in Obstructive Sleep Apnea Syndrome with Hypertension As the Blood Pressure Classification

Non-Alcoholic Fatty Liver Disease and Hypokalemia in Primary Aldosteronism among Chinese Population.

Screening parameters for diagnosing primary aldosteronism in patients with moderate to severe obstructive sleep apnea hypopnea syndrome and resistant hypertension

Primary aldosteronism and obstructive sleep apnea: What do we know thus far?

Associations between primary aldosteronism and diabetes, poor bone health, and sleep apnea—what do we know so far?

Electrical and Myocardial Remodeling in Primary Aldosteronism

New-Onset Atrial Fibrillation in Patients With Primary Aldosteronism Receiving Different Treatment Strategies: Systematic Review and Pooled Analysis of Three Studies

PS-BPC01-2: PREDICTORS AND EFFECTS OF COMORBID ATRIAL FIBRILLATION IN HYPERTENSIVE PATIENTS DUE TO PRIMARY ALDOSTERONISM

Arterial Stiffness Changes and Plasma Renin-Angiotensin-Aldosterone in Patients with Hypertention and Obstructive Sleep Apnea-Hypopnea Syndrome

Primary aldosteronism and obstructive sleep apnea: the strong ties between them

648 ANALYSIS OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH PRIMARY ALDOSTERONISM

Urine biomarkers of renal renin-angiotensin system activity: Exploratory analysis in humans with and without obstructive sleep apnea

The Role of Aldosterone in OSA and OSA-Related Hypertension